These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 305123)

  • 1. Fusion of T and B cells.
    Köhler G; Pearson T; Milstein C
    Somatic Cell Genet; 1977 May; 3(3):303-12. PubMed ID: 305123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T lymphocyte-mediated suppression of myeloma function in vitro. III. Regulation of antibody production in hybrid myeloma cells by T lymphocytes.
    Abbas AK; Burakoff SJ; Gefter ML; Greene MI
    J Exp Med; 1980 Oct; 152(4):969-78. PubMed ID: 6158552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential activation and loss of the pre-B cell Thy-1 gene in T-cell X pre-B cell somatic hybrids.
    Hyman R; Clarkin K
    Immunogenetics; 1988; 27(5):313-21. PubMed ID: 2895732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of amplified synthesis and secretion of IgM by fusion of murine 'b lymphoma with myeloma cells.
    Laskov R; Kim KJ; Asofsky R
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):915-9. PubMed ID: 311476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of light chain synthesis in myeloma x spleen cell hybrids and identification of myeloma chain loss variants using radioimmunoassay.
    Springer TA
    J Immunol Methods; 1980; 37(2):139-52. PubMed ID: 6777428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of Thy-1 antigen in L-cell X mouse lymphoma hybrids.
    Hyman R; Kelleher RJ
    Somatic Cell Genet; 1975 Oct; 1(4):335-43. PubMed ID: 1088379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human lymphocyte-mouse myeloma somatic cell hybrids: selective hybrid formation.
    Schwaber J
    Somatic Cell Genet; 1977 May; 3(3):295-302. PubMed ID: 305122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of spleen cell immunoglobulin phenotype in hybrids with myeloma cell lines.
    Clark MR; Milstein C
    Somatic Cell Genet; 1981 Nov; 7(6):657-66. PubMed ID: 7323946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes.
    Larizza L; Schirrmacher V; Stöhr M; Pflüger E; Dzarlieva R
    J Natl Cancer Inst; 1984 Jun; 72(6):1371-81. PubMed ID: 6610070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological activity of a T hybrid line. I. Production of an H-2-related suppressor factor with specificity for sheep red blood cells.
    Taussig MJ; Corvalán JR; Binns RM; Roser B; Holliman A
    Eur J Immunol; 1979 Oct; 9(10):768-76. PubMed ID: 93051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Thy 1.2 antigen on hybrids of B cells and a T lymphoma.
    Iverson GM; Goldsby RA; Herzenberg LA
    Curr Top Microbiol Immunol; 1978; 81():192-4. PubMed ID: 308440
    [No Abstract]   [Full Text] [Related]  

  • 12. Interspecies spleen-myeloma hybrid producing monoclonal antibodies against mouse lymphocyte surface glycoprotein, T200.
    Trowbridge IS
    J Exp Med; 1978 Jul; 148(1):313-23. PubMed ID: 78961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell hybrids that express a VH idiotope-related determinant on a glycoprotein distinct from H-2, Thy-1, and Lyt-1 molecules.
    Chanh TC; Cooper MD
    J Exp Med; 1983 Aug; 158(2):452-64. PubMed ID: 6193222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid cell lines secreting monoclonal antibody specific for major histocompatibility antigens of the mouse.
    Lemke H; Hammerling GJ; Hohmann C; Rajewsky K
    Nature; 1978 Jan; 271(5642):249-51. PubMed ID: 74805
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of the teratocarcinoma phenotype in hybrids between totipotent mouse teratocarcinoma and myeloma cells.
    Correani A; Croce CM
    J Cell Physiol; 1980 Oct; 105(1):73-9. PubMed ID: 7430268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell hybrids: an important new source of antibody production.
    Blann AD
    Med Lab Sci; 1979; 36(4):329-38. PubMed ID: 392214
    [No Abstract]   [Full Text] [Related]  

  • 17. T-cell hybrids as a source of antigen-specific factors.
    Taussig MJ; Holliman A; Corvalán JR
    Transplant Proc; 1980 Sep; 12(3):427-31. PubMed ID: 6164137
    [No Abstract]   [Full Text] [Related]  

  • 18. Construction of T cell hybridomas secreting allogeneic effect factor.
    Katz DH; Bechtold TE; Altman A
    J Exp Med; 1980 Oct; 152(4):956-68. PubMed ID: 6158551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.
    Kappler JW; Skidmore B; White J; Marrack P
    J Exp Med; 1981 May; 153(5):1198-214. PubMed ID: 6166712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific suppressive factors produced by hybridomas derived from the fusion of enriched suppressor T cells and a T lymphoma cell line.
    Taniguchi M; Miller JF
    J Exp Med; 1978 Aug; 148(2):373-82. PubMed ID: 308978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.